1. Home
  2. XYL vs RMD Comparison

XYL vs RMD Comparison

Compare XYL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYL
  • RMD
  • Stock Information
  • Founded
  • XYL 2011
  • RMD 1989
  • Country
  • XYL United States
  • RMD United States
  • Employees
  • XYL N/A
  • RMD N/A
  • Industry
  • XYL Fluid Controls
  • RMD Medical/Dental Instruments
  • Sector
  • XYL Industrials
  • RMD Health Care
  • Exchange
  • XYL Nasdaq
  • RMD Nasdaq
  • Market Cap
  • XYL 28.8B
  • RMD 32.5B
  • IPO Year
  • XYL N/A
  • RMD 1995
  • Fundamental
  • Price
  • XYL $110.97
  • RMD $213.34
  • Analyst Decision
  • XYL Buy
  • RMD Buy
  • Analyst Count
  • XYL 10
  • RMD 11
  • Target Price
  • XYL $149.89
  • RMD $253.88
  • AVG Volume (30 Days)
  • XYL 1.7M
  • RMD 905.9K
  • Earning Date
  • XYL 04-29-2025
  • RMD 04-24-2025
  • Dividend Yield
  • XYL 1.44%
  • RMD 0.99%
  • EPS Growth
  • XYL 30.82
  • RMD 40.24
  • EPS
  • XYL 3.65
  • RMD 8.47
  • Revenue
  • XYL $8,562,000,000.00
  • RMD $4,926,773,000.00
  • Revenue This Year
  • XYL $2.98
  • RMD $10.07
  • Revenue Next Year
  • XYL $5.29
  • RMD $7.35
  • P/E Ratio
  • XYL $30.46
  • RMD $25.31
  • Revenue Growth
  • XYL 16.27
  • RMD 9.38
  • 52 Week Low
  • XYL $110.89
  • RMD $172.19
  • 52 Week High
  • XYL $146.08
  • RMD $263.05
  • Technical
  • Relative Strength Index (RSI)
  • XYL 26.09
  • RMD 35.95
  • Support Level
  • XYL $116.52
  • RMD $215.05
  • Resistance Level
  • XYL $120.30
  • RMD $223.56
  • Average True Range (ATR)
  • XYL 2.50
  • RMD 4.99
  • MACD
  • XYL -0.72
  • RMD 0.02
  • Stochastic Oscillator
  • XYL 0.22
  • RMD 10.13

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: